| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0004 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0008 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |